Patents expiring in 2035

US 9085577

7-aryl-1,2,4-triazolo[4,3-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors

Addex Pharma, S.A. · Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9084828

Oligomer-protein tyrosine kinase inhibitor conjugates

Nektar Therapeutics · Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9084761

Use of interleukin-15 to treat cardiovascular diseases

THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9085757

Production of insulin producing cells

Regents of the University of Minnesota · Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9086420

Methods for identifying analgesic agents

Xenon Pharmaceuticals Inc. · Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9084808

Modified small interfering RNA molecules and methods of use

Arrowhead Research Corporation · Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9090573

Compounds as lysophosphatidic acid receptor antagonists

AMIRA PHARMACEUTICALS, INC. · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9090630

Macrocyclic FLT3 kinase inhibitors

Oncodesign SA · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9090712

Diagnosis of carcinomas

PACIFIC NORTHWEST RESEARCH INSTITUTE · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9090895

Compositions and methods for inhibiting expression of the HAMP gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9091696

Modulation of NR2F6 and methods and uses thereof

Regen Biopharma, Inc. · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9090597

Pyrazolone derivatives as PDE4 inhibitors

TAKEDA GMBH · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9091701

Disease severity index for assessment of chronic liver disease and method for diagnosis of three distinct subtypes of primary sclerosing cholangitis

The Regents of the University of Colorado, a Body Corporate · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9090740

Methods for preparing polymeric reagents

Nektar Therapeutics · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9090619

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9089482

Dental mill blank

KURARAY NORITAKE DENTAL INC. · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9089498

Multifunctional nanoparticle designs and applications

The Regents of the University of California · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9089156

Reducing muscle soreness with glucosamine compositions

Stokely-Van Camp, Inc. · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9090873

Development of dengue virus vaccine components

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9089515

Long chain N-alkyl compounds and oxa-derivatives thereof

United Therapeutics Corporation · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9090933

Cancer screening by detection of ultrastructural and molecular markers

Northwestern University · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9089531

GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes

The Regents of the University of California · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9089566

Delivery of therapeutic compounds to the brain and other tissues

BIOMARIN PHARMACEUTICAL INC. · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9089599

Low affinity FCGR deficient mice

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9089610

Complexes of small-interfering nucleic acids

Nektar Therapeutics · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9089677

Transcutaneous multimodal delivery system (TMDS)

The Regents of the University of California · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9089555

Complement antagonists and uses thereof

REGENESANCE B.V. · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9089556

Method for treating cancer using an antibody that inhibits notch4 signaling

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9089611

Poly(vinyl ester) polymers for in vivo nucleic acid delivery

Arrowhead Madison, Inc. · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9089698

Method and apparatus for optogenetic treatment of blindness including retinitis pigmentosa

The Regents of the University of California · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9090535

Hydroxylated tricyclic compounds

Nektar Therapeutics · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9090586

Heterocyclic compound

Takeda Pharmaceutical Company Limited · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9090589

Specific nNOS inhibitors for the therapy and prevention of human melanoma

The Regents of the University of California · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9090598

Nilotinib salts and crystalline forms thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9090614

Processes and intermediates for producing azaindoles

Vertex Pharmaceuticals Incorporated · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9089506

Stable, non-irritating topical formulations of hydroquinone

Precision Dermatology, Inc. · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9089545

Small molecule RNase inhibitors and methods of use

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

FR 3016881

TRAITEMENT DES DEGENERESCENCES ET DES LESIONS PHOTO-INDUITES DE LA RETINE

BIOCODEX [FR] · Granted Fri Jul 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu Jul 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9096499

Compounds for treatment of cell proliferative diseases

The Board of Regents of the University of Texas System · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9096543

Nuclear transport modulators and uses thereof

Karyopharm Therapeutics Inc. · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9096584

Compounds useful as inhibitors of ATR kinase

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9096602

Substituted pyrrolo[2,3-B]pyrazines as ATR kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9096608

Pharmaceutically active pyrazolo-triazine derivatives

Lead Discovery Center GmbH · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9096609

Macrocyclic LRRK2 kinase inhibitors

Oncodesign SA · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9096642

Therapeutic compounds for immunomodulation

Aurigene Discovery Technologies Limited · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9096637

Organic compositions to treat HSF1-related diseases

Arrowhead Research Corporation · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9096647

Simplified one-pot synthesis of [18F]SFB for radiolabeling

The Regents of the University of California · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9096689

Methods and compositions for inhibiting angiogenesis

Northwestern University · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)